VIDEX Drug Patent Profile

✉ Email this page to a colleague

When do Videx patents expire, and when can generic versions of Videx launch?

Videx is a drug marketed by Bristol and Bristol Myers Squibb and is included in four NDAs.

The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.

Summary for VIDEX

US Patents:	0
Applicants:	2
NDAs:	4
Raw Ingredient (Bulk) Api Vendors:	123
Patent Applications:	4,330
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VIDEX
What excipients (inactive ingredients) are in VIDEX?	VIDEX excipients list
DailyMed Link:	VIDEX at DailyMed

Drug patent expirations by year for VIDEX

Anatomical Therapeutic Chemical (ATC) Classes for VIDEX

J05AF	Nucleoside and nucleotide reverse transcriptase inhibitors
J05A	DIRECT ACTING ANTIVIRALS
J05	ANTIVIRALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

Paragraph IV (Patent) Challenges for VIDEX

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VIDEX	Capsules	didanosine	75 mg	020155	1	2011-06-06

US Patents and Regulatory Information for VIDEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bristol	VIDEX	didanosine	FOR SOLUTION;ORAL	020156-001	Oct 9, 1991		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	TABLET, CHEWABLE;ORAL	020154-003	Oct 9, 1991		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	FOR SOLUTION;ORAL	020155-005	Oct 9, 1991		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bristol Myers Squibb	VIDEX EC	didanosine	CAPSULE, DELAYED REL PELLETS;ORAL	021183-002	Oct 31, 2000		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	TABLET, CHEWABLE;ORAL	020154-004	Oct 9, 1991		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bristol Myers Squibb	VIDEX EC	didanosine	CAPSULE, DELAYED REL PELLETS;ORAL	021183-004	Oct 31, 2000		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VIDEX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol	VIDEX	didanosine	FOR SOLUTION;ORAL	020156-001	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	FOR SOLUTION;ORAL	020155-003	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	TABLET, CHEWABLE;ORAL	020154-002	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	FOR SOLUTION;ORAL	020155-003	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	TABLET, CHEWABLE;ORAL	020154-002	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
Bristol Myers Squibb	VIDEX	didanosine	TABLET, CHEWABLE;ORAL	020154-005	Oct 9, 1991	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VIDEX

See the table below for patents covering VIDEX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Ireland	922365		⤷ Try a Trial
Japan	H05194234	IMPROVED PRESCRIPTION OF DIDEOXYPURINE NUCLEOSIDE FOR ORAL ADMINISTRATION	⤷ Try a Trial
Luxembourg	88475		⤷ Try a Trial
Spain	2113389		⤷ Try a Trial
European Patent Office	0493378		⤷ Try a Trial
Ireland	64518	Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxyinosine 2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for VIDEX

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0216510	94C0006	Belgium	⤷ Try a Trial	PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505
0216510	SZ 54/1994	Austria	⤷ Try a Trial	PRODUCT NAME: 2',3'-DIDEOXYINOSIN
0216510	SPC/GB94/005	United Kingdom	⤷ Try a Trial	SPC/GB94/005:, EXPIRES: 20070504
0285237	94C0006	France	⤷ Try a Trial	PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for VIDEX

Anatomical Therapeutic Chemical (ATC) Classes for VIDEX

Paragraph IV (Patent) Challenges for VIDEX

Make Better Decisions: Try a trial or see plans & pricing